期刊文献+

DNA甲基化与肿瘤诊断 被引量:1

DNA methylation and tumor disease
下载PDF
导出
摘要 DNA甲基化异常是人类肿瘤中常见的表观遗传变化之一,伴随着肿瘤的发生和发展,且该异常现象在肿瘤患者的外周循环血清、血浆和尿液等体液中都可检测到。因此,利用DNA甲基化分析技术检测体液中特定分子DNA甲基化水平是肿瘤早期诊断、病程监控和疗效评估的潜在手段,对临床肿瘤的诊治意义重大。 Abnormal methylation of DNA in certain genomic regions is a frequent epigenetic alteration that is involved in Human tumorigenesis and development. Various studies have shown that this aberrant DNA modification can be detected in body fluids of tumor patients, e. g. circulating blood, sputum, urine. So the evaluation of DNA methylation in these body fluids by methylaion detection methods can be utilized as a potential biomarker for early cancer detection and accurately clinical assess. This plays a significant role in cancer diagnosis and treatment.
出处 《中国临床药理学与治疗学》 CAS CSCD 2006年第2期131-135,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 上海市科委重大科技攻关项目资助课题(№04DZ19211)
关键词 DNA甲基化 二核苷酸胞嘧啶岛 表观遗传 DNA甲基转移酶 肿瘤诊断 DNA methylation CpG island epigenetics DNA methyl-transferase tumor diagnose
  • 相关文献

参考文献27

  • 1Jaenisch R,Bird A.Epigenetic regulation of gene expression:how the genome integrates intrinsic and environmental signals[J].Nature Genet,2003;33:245-54
  • 2Bird A.DNA methylation patterns and epigenetic memory[J].Genes Dev,2002;16:6-21
  • 3Robertson KD.DNA methylation and human disease[J].Nature Reviews Genetics,2005;6:597-610
  • 4Fuks F,Hurd PJ,Wolf D.The methyl CpG binding protein MeCP links DNA methylation to histone methylatin[J].J Bilo Chem,2003;278:4035-40
  • 5Rhee I,Jair KW,Yen RW,Lengauer C,Herman JG,Kinzler KW,et al.CpG methylation is maintained in human cancer cells lacking DNMT1[J].Nature,2000;404:1003-7
  • 6Rhee I,Bachman KE,Park BH,Jair KW,Yen RW,Schuebel KE,et al.DNMT1 and DNMT3b cooperate to silence genes in human cancer cells[J].Nature,2002;416:552-6
  • 7Hochedlinger K,Blelloch R,Brennan C,Yamada Y,Kim M,Chin L,et al.Reprogramming of a melanoma genome by nuclear transplantation[J].Genes Dev,2004;18:1875-85
  • 8Szyf M,Pakneshan P,Rabbani SA.DNA methylation and breast cancer[J].Biochem Pharmacol,2004;68:1187-97
  • 9Takashi T,Hiroaki S,Mikio I,Hideki E,Shinji U,Toshifumi K,et al.Cytochrome P450 1B1 Is Overexpressed and Regulated by Hypomethylation in Prostate Cance[J].Clin Cancer Res,2005;11:5793-801
  • 10Li LC,Okino ST,Dahiya R.DNA methylation in prostate cancer[J].Biochim Biophys Acta,2004;1704:87-102

同被引文献17

  • 1屠红,高海峰,傅士龙,陈颢.肿瘤患者循环DNA的定量研究[J].中华肿瘤杂志,2004,26(10):606-608. 被引量:8
  • 2今毅,谢文,余小萍,郑晖.乳腺癌患者肿瘤循环DNA的定量分析[J].第四军医大学学报,2007,28(11):1024-1026. 被引量:8
  • 3Wong BC, Lo YM. Cell-free DNA and RNA in plasma as new tools for molecular diagnostics[J]. Expert Rev Mol Diagn,2003,3(6):785-797.
  • 4Ziegler A, Zangemeister-Wittke U, Stahel RA, et al. Circulating DNA: a new diagnostic gold mine [J]? Cancer Treat Rev,2002,28(5):255-271.
  • 5Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients:quantitations and evidence for their origin from apoptotic and necrotic cells[J]. Cancer Res, 2001, 61 (4): 1659-1665.
  • 6Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of the therapy[J]. Cancer Res, 1977,37 (3) : 646 - 650.
  • 7Maebo A. Plasma DNA level as a tumor marker in primary lung cancer [ J ]. Nihon Kyobu Shikkan Gakkai Zasshi,1990,28(8) : 1085-1091.
  • 8Fournie GJ, Courtin JP, Laval F, et al. Plasma DNA as a marker of cancerous cell death, investigations in patients suffering from lung cancer and in nude mice bearing human tumours[J]. Cancer lett, 1995, 91 (2):221-227.
  • 9Gautsehi O, Bigoseh C, Huegli B, et al. Circulating deoxyribonucleic acid as prognostic marker in non small cell lung cancer patients undergoing chemotherapy[J]. Clin Oncol,2004,22(20) :4157-4164.
  • 10Sozzi G, Conte D, Mariani L, et al. Analysis of circu lating tumor DNA in plasma at diagnosis and during follow up of lung cancer patients[J]. Cancer Res, 2001,61(12) :4675-4678.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部